IC

Ikarian Capital, LLC

13F
Ikarian Capital, LLC
Last update 2024-11-14 145 Stocks (20 new)
Value $717.00 Mil Turnover 16 %
Countries:
Top Holdings: TARS(4.73%)CRNX(3.04%)ELVN(1.78%)RCUS(1.59%)VRDN(1.59%)
Portfolio Report
Summary Stock Picks Current Portfolio
Ikarian Capital, LLC Top Holdings of 2024-09-30 View Full List
Ticker
XBI PUT
AMGN CALL
VRTX CALL
VRTX PUT
TARS
CRNX
JANX PUT
BHVN PUT
IMVT CALL
ANAB PUT
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
XBI PUT 		SPDR Biotech ETF
500,000
49400.000
0%
6.890
0%
0.690
-7.04%
-0.69%
6216.327
 
AMGN CALL 		Amgen Inc
146,000
47042.660
0%
6.560
0%
0.030
-17.66%
+0.61%
140957.206
Drug Manufacturers
VRTX CALL 		Vertex Pharmaceuticals Inc
100,000
46508.000
0%
6.490
0%
0.040
-13.99%
+1.70%
105473.696
Biotechnology
VRTX PUT 		Vertex Pharmaceuticals Inc
100,000
46508.000
0%
6.490
0%
0.040
-13.99%
+1.70%
105473.696
Biotechnology
TARS 		Tarsus Pharmaceuticals Inc
1,030,277
33885.810
+28.74%
4.730
+1.06%
2.710
+48.42%
-4.84%
2014.177
Biotechnology
CRNX 		Crinetics Pharmaceuticals Inc
426,913
21815.260
-27.50%
3.040
-1.26%
0.470
-21.61%
-20.61%
3764.220
Biotechnology
JANX PUT 		Janux Therapeutics Inc
365,200
16591.040
0%
2.310
0%
0.700
-0.97%
-12.66%
2741.670
Biotechnology
BHVN PUT 		Biohaven Ltd
325,600
16270.230
0%
2.270
0%
0.320
-28.63%
-1.69%
3713.209
Biotechnology
IMVT CALL 		Immunovant Inc
500,000
14255.000
0%
1.990
0%
0.340
-21.55%
-5.21%
3446.503
Biotechnology
ANAB PUT 		AnaptysBio Inc
404,300
13544.050
0%
1.890
0%
1.330
-55.59%
+7.33%
432.392
Biotechnology

Ikarian Capital, LLC's Historical Top Holdings Breakdowns

Ikarian Capital, LLC's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
SLRN 		Acelyrin Inc2023-06-30New Buy
+9.71%
●
16.97 ($20.46) 25.37
$2.06
-89.93%
New holding
2,918,426
2,918,426
RXDX Prometheus Biosciences Inc2023-03-31Reduce
-4.33%
●
103.46 ($115.1) 126.29
$199.92
73.69%
Reduce -56.42%
125,926
-163,000
SRPT 		Sarepta Therapeutics Inc2024-09-30Reduce
-4.11%
●
124.33 ($138.24) 156.75
$124.79
-9.73%
Reduce -73.39%
54,176
-149,436
RXDX Prometheus Biosciences Inc2023-06-30Sold Out
-3.07%
●
107.32 ($180.27) 199.92
$199.92
10.90%
Sold Out
0
-125,926
IMVT 		Immunovant Inc2023-06-30Sold Out
-2.73%
●
14.2 ($18.6) 23.75
$23.48
26.24%
Sold Out
0
-774,398
ARGX 		argenx SE2023-12-31New Buy
+2.48%
●
338.91 ($465.95) 506.01
$656.26
40.84%
New holding
70,000
70,000
ARGX 		argenx SE2024-03-31Sold Out
-2.48%
●
356.95 ($387.4) 413.29
$656.26
69.40%
Sold Out
0
-70,000
HZNP Horizon Therapeutics PLC2023-03-31Sold Out
-2.45%
●
107.32 ($110.54) 113.5
$116.30
5.21%
Sold Out
0
-89,219
MRK 		Merck & Co Inc2023-03-31New Buy
+2.41%
●
102.94 ($107.97) 114.84
$99.25
-8.08%
New holding
100,000
100,000
ELVN 		Enliven Therapeutics Inc2024-06-30New Buy
+2.39%
●
16.78 ($21.05) 24.7
$21.74
3.28%
New holding
586,552
586,552

Ikarian Capital, LLC Total Holding History ($B)

To

Ikarian Capital, LLC's Asset Allocation

To

Ikarian Capital, LLC Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Ikarian Capital, LLC's Hypothetical Growth since 2024-09-30

Ikarian Capital, LLC's Yearly Returns

Year Portfolio % % Excess Gain %

Ikarian Capital, LLC's Holdings Heat Map

Size field:

Ikarian Capital, LLC's Holdings Bubble Chart

Ikarian Capital, LLC News

  • 1

Discussions on Ikarian Capital, LLC

No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.